SCHEMBL8306623

SCHEMBL8306623

CC(=NO)c1ccc(-c2ccncc2)cc1CCOC1CCCCO1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
AAK1 Q2M2I8 3/20 0.34
ADORA3 P0DMS8 1/20 0.32
MET P08581 2/20 0.32
ROCK2 O75116 2/20 0.31
TSHR P16473 1/20 0.30
RECQL P46063 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
ICAM1 P05362 1/20 0.30
SELE P16581 1/20 0.30
ESR1 P03372 1/20 0.30
ESR2 Q92731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8309323 0.90 KDM4C (0.39) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8308439 0.89 KDM4C (0.37) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8304994 0.89 L3MBTL1 (0.45) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8305972 0.89 KDM4C (0.42) KDM4CNPC1RAB9AL3MBTL1ADORA3
SCHEMBL5610112 0.88 NPC1 (0.48) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL6933894 0.85 KDM4C (0.44) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8305428 0.81 KDM4C (0.37) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8307195 0.80 RAB9A (0.45) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8304159 0.80 KDM4C (0.41) KDM4CNPC1RAB9AL3MBTL1MEN1
SCHEMBL8309584 0.76 KDM4C (0.40) KDM4CNPC1RAB9AL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed